Navin Fluorine International Ltd Q2FY26 – From Coolants to Cool Profits: The Chemist Who Turned a Gas Leak Into a Fortune
1. At a Glance – The “Fluorine” That Outshone Gold
What happens when a 1960s refrigerant pioneer decides to reinvent itself as a high-tech fluorochemicals empire? You get Navin Fluorine International Ltd (NFIL) — India’s coolest cash compounder with a market cap of ₹25,503 crore, trading at a frosty P/E of 57.4x, and still making investors sweat from FOMO.
The Q2FY26 numbers were, well, explosive: revenue rose 46% YoY to ₹758 crore, and profit rocketed 152% YoY to ₹148 crore. Operating margins inflated to 32%, from just 21% a year ago. The company even threw in an interim dividend of ₹6.5 per share just to remind everyone that chemistry pays.
But it’s not just about gases and reactions — NFIL’s ROE (11.5%) and ROCE (11.7%) show a steady climb post its capex-heavy FY24 phase. With a current ratio of 2.75, debt-to-equity of 0.33x, and operating profits humming at ₹779 crore TTM, this lab is bubbling again.
At ₹4,977, the stock sits closer to the periodic table’s “expensive elements,” but the market clearly believes the formula is working.
2. Introduction – How to Turn Hydrofluoric Dreams Into Hard Cash
Let’s be honest — fluorine chemistry sounds like the kind of thing that belongs in a nuclear lab, not a stock portfolio. Yet, Navin Fluorine has turned it into an empire. Born in 1967 under the Padmanabh Mafatlal Group, this company started off selling refrigerant gases (yes, the same ones your old AC used). But as the world moved toward eco-friendly cooling and high-value molecules, NFIL morphed from a gas vendor into a global specialty chemical wizard.
Today, it sits comfortably at the intersection of chemistry, climate, and capital — producing everything from high-performance refrigerants to pharma-grade fluorinated compounds used in life-saving drugs and agrochemicals.
The company’s reinvention over the last decade has been nothing short of a PhD thesis in “Strategic Evolution 101.” It diversified into CDMO (Contract Development and Manufacturing), built greenfield plants at Dahej, and secured multi-year contracts with Honeywell and European API players.
But here’s the punchline: while the planet is busy phasing out old-school R-22 gases, NFIL is already making its replacements — R-32 and new-age HFOs (Hydrofluoro-olefins). From climate villain to green-tech darling — what a character arc!
Question to readers: When was the last time a refrigerant stock gave you 49% annual returns without melting down?
3. Business Model – WTF Do They Even Do?
Navin Fluorine runs four very distinct but interlinked chemical businesses:
High-Performance Products (HPP) – 46% of FY24 Revenue: Think advanced refrigerants and inorganic fluorides. It’s the company’s legacy business, but also the one undergoing massive modernization. Their long-term $410 million contract with Honeywell is a crown jewel here.
Specialty Chemicals – 41% of FY24 Revenue: These are the fancy fluorinated intermediates used in agrochemicals and pharmaceuticals — high margin, IP-heavy, and where NFIL’s chemistry prowess shines brightest.
CDMO (Contract Research & Manufacturing) – 13% of FY24 Revenue: This is the service-based model — developing and manufacturing molecules for global pharma innovators. The company has even set up cGMP facilities at Dewas, with a new cGMP-4 unit under commissioning.
Emerging HFO Segment: HFOs (hydro-fluoro-olefins) are the “cool” gases of the future — low GWP, ozone-safe, and in huge demand from refrigeration, automotive, and data-center cooling industries.
In short: NFIL isn’t selling chemicals — it’s selling climate compliance and molecular complexity. And doing it profitably.
Commentary: This is the chemical industry equivalent of a supernova. Revenue nearly doubled in two years, margins exploded from 21% to 32%, and profits are up 150% YoY. Clearly, those new HPP lines and CDMO contracts are working like catalysts — no wonder the market’s reacting so exothermically.
5. Valuation Discussion – Where the Chemistry Meets Arithmetic
a) P/E Method: EPS (TTM) = ₹88.6 Industry P/E = ~32x Fair Value Range = ₹88.6 × (40–60x) = ₹3,540 – ₹5,316
b) EV/EBITDA Method: EV = ₹26,608 Cr; EBITDA = ₹779 Cr → EV/EBITDA = 34x
